• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与糖肽类抗生素作用模式相关的不对称二聚体结构。

The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.

作者信息

Groves P, Searle M S, Mackay J P, Williams D H

机构信息

Cambridge Centre for Molecular Recognition, University Chemical Laboratories, UK.

出版信息

Structure. 1994 Aug 15;2(8):747-54. doi: 10.1016/s0969-2126(94)00075-1.

DOI:10.1016/s0969-2126(94)00075-1
PMID:7994574
Abstract

BACKGROUND

Glycopeptide antibiotics of the vancomycin group are of crucial clinical importance in the treatment of methicillin resistant Staphylococcus aureus (MRSA)--the often lethal 'super-bug'--characterized by its resistance to a wide range of antibiotics in common use. The antibiotics exert their physiological action by blocking cell wall synthesis through recognition of nascent cell wall mucopeptides terminating in the sequence -D-Ala-D-Ala. Evidence suggests that the antibiotics are able to enhance their biological activity by the formation of homodimers, and this is supported by the observation that dimerization and peptide binding in vitro are cooperative phenomena. The basis of this enhancement is not understood at the molecular level.

RESULTS

The first detailed structure of a dimeric glycopeptide antibiotic, that of eremomycin, is presented based upon solution NMR data. The overall structure of the dimer complex is asymmetric. The source of this asymmetry--a parallel alignment and mutual interaction of the disaccharides--appears to promote dimerization through specific sugar-sugar recognition.

CONCLUSIONS

A molecular basis for the observed cooperativity of cell wall peptide binding by eremomycin is evident from these studies of the dimer. The carboxylate anion of the cell wall component, which is crucial to binding, forms an amide-mediated ion-pair interaction to the alkylammonium ion of the ring 6 sugar in the other half of the dimer making the structure and positioning of this sugar important in mediating cooperativity.

摘要

背景

万古霉素类糖肽抗生素在治疗耐甲氧西林金黄色葡萄球菌(MRSA)——这种通常致命的“超级细菌”方面具有至关重要的临床意义,其特点是对多种常用抗生素具有耐药性。这些抗生素通过识别以-D-丙氨酰-D-丙氨酸序列结尾的新生细胞壁粘肽来阻断细胞壁合成,从而发挥其生理作用。有证据表明,这些抗生素能够通过形成同二聚体来增强其生物活性,体外二聚化和肽结合是协同现象这一观察结果也支持了这一点。这种增强作用在分子水平上的基础尚不清楚。

结果

基于溶液核磁共振数据,给出了二聚体糖肽抗生素埃瑞霉素的首个详细结构。二聚体复合物的整体结构是不对称的。这种不对称性的来源——二糖的平行排列和相互作用——似乎通过特定的糖-糖识别促进了二聚化。

结论

从对二聚体的这些研究中可以明显看出埃瑞霉素结合细胞壁肽时观察到的协同作用的分子基础。对结合至关重要的细胞壁成分的羧酸根阴离子与二聚体另一半中6位环糖上的烷基铵离子形成酰胺介导的离子对相互作用,这使得该糖的结构和定位在介导协同作用中很重要。

相似文献

1
The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.与糖肽类抗生素作用模式相关的不对称二聚体结构。
Structure. 1994 Aug 15;2(8):747-54. doi: 10.1016/s0969-2126(94)00075-1.
2
Crystal structure of vancomycin.万古霉素的晶体结构。
Structure. 1996 Dec 15;4(12):1509-15. doi: 10.1016/s0969-2126(96)00156-6.
3
Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.糖肽类抗生素苷元与细胞壁类似物的结构及结合的量子模拟
J Phys Chem B. 2005 Nov 3;109(43):20588-96. doi: 10.1021/jp0548117.
4
Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.万古霉素与细胞壁前体类似物复合物的晶体结构。
J Mol Biol. 2009 Feb 6;385(5):1422-32. doi: 10.1016/j.jmb.2008.10.026. Epub 2008 Oct 19.
5
New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.利用表面等离子体共振(SPR)和核磁共振(NMR)光谱对糖肽类抗生素与细胞壁前体结合的新见解。
Chemistry. 2014 Jun 10;20(24):7363-72. doi: 10.1002/chem.201303310. Epub 2014 May 7.
6
Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.糖肽类抗生素埃瑞霉素及其去(N-甲基-D-亮氨酰)埃瑞霉素的疏水衍生物对糖肽敏感菌和耐药菌的合成及作用模式
J Med Chem. 2002 Mar 14;45(6):1340-7. doi: 10.1021/jm010460i.
7
An analysis of the origins of a cooperative binding energy of dimerization.
Science. 1998 May 1;280(5364):711-4. doi: 10.1126/science.280.5364.711.
8
Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.A82846B、万古霉素和瑞斯托菌素的二聚化:对与细胞壁模型肽的抗生素络合的影响
J Antibiot (Tokyo). 1996 Feb;49(2):181-93. doi: 10.7164/antibiotics.49.181.
9
Calculation of concentrations of equilibrium components in an in vitro activity test of vancomycin antibiotics and the possible mode of action.万古霉素类抗生素体外活性测试中平衡组分浓度的计算及可能的作用方式。
Biophys Chem. 1998 Aug 24;74(2):107-15. doi: 10.1016/s0301-4622(98)00172-0.
10
Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.糖肽万古霉素与细菌细胞壁肽类似物之间的分子相互作用。
Chemistry. 2011 Dec 9;17(50):14170-7. doi: 10.1002/chem.201102195. Epub 2011 Nov 14.

引用本文的文献

1
Glycopeptides: Insights Towards Resistance, Clinical Pharmacokinetics and Pharmacodynamics.糖肽类抗生素:耐药性、临床药代动力学及药效学研究进展
Indian J Microbiol. 2025 Mar;65(1):32-50. doi: 10.1007/s12088-024-01273-y. Epub 2024 Apr 27.
2
Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity.埃瑞莫霉素的氨基烷基酰胺表现出增强的抗菌活性。
Pharmaceuticals (Basel). 2021 Apr 19;14(4):379. doi: 10.3390/ph14040379.
3
Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies.
细菌细胞壁类似物肽调控糖肽类抗生素埃瑞霉素的寡聚状态和活性:溶液核磁共振及抗菌研究
Pharmaceuticals (Basel). 2021 Jan 22;14(2):83. doi: 10.3390/ph14020083.
4
The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins.抗生素万古霉素诱导胃肠道和颌下黏液的复合化和聚集。
Sci Rep. 2020 Jan 22;10(1):960. doi: 10.1038/s41598-020-57776-3.
5
Minimal exposure of lipid II cycle intermediates triggers cell wall antibiotic resistance.脂质 II 循环中间产物的最小暴露会引发细胞壁抗生素耐药性。
Nat Commun. 2019 Jun 21;10(1):2733. doi: 10.1038/s41467-019-10673-4.
6
Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures.对万古霉素与细菌细胞壁结构之间关键相互作用的见解
ACS Omega. 2018 Jan 31;3(1):37-45. doi: 10.1021/acsomega.7b01483. Epub 2018 Jan 4.
7
Full hydrodynamic reversibility of the weak dimerization of vancomycin and elucidation of its interaction with VanS monomers at clinical concentration.万古霉素弱二聚化的完全流体动力学可逆性及其与临床浓度下 VanS 单体相互作用的阐明。
Sci Rep. 2017 Oct 5;7(1):12697. doi: 10.1038/s41598-017-12620-z.
8
Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci.肠球菌中 VanS 受体对调控 A 型万古霉素耐药性的抗生素万古霉素和替考拉宁的选择性结合特性。
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):1951-1959. doi: 10.1016/j.bbagen.2017.05.011. Epub 2017 May 13.
9
Hydrodynamics of the VanA-type VanS histidine kinase: an extended solution conformation and first evidence for interactions with vancomycin.VanA 型 VanS 组氨酸激酶的流体动力学:扩展的溶液构象和与万古霉素相互作用的初步证据。
Sci Rep. 2017 Apr 11;7:46180. doi: 10.1038/srep46180.
10
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections.奥塔万星概述及其在治疗急性细菌性皮肤结构感染中的潜力。
Infect Drug Resist. 2015 Jul 6;8:189-97. doi: 10.2147/IDR.S69412. eCollection 2015.